Concepedia

Seng Jingjing

SJ

Statistics

Publications

6

Citations

207

H-Index

6

Active since

2003

Affiliations

First Affiliated Hospital of Zhengzhou University(Current)

Seng Jingjing is an author at First Affiliated Hospital of Zhengzhou University specializing in oncology, molecular oncology, and medicine.

ORCID

Publications per year

2003–2019

6

Publications

6

Long non‐coding <scp>RNA FTH</scp>1P3 activates paclitaxel resistance in breast cancer through miR‐206/<scp>ABCB</scp>1

Ruoming Wang, Tengteng Zhang, Zhen Yang et al. · Journal of Cellular and Molecular Medicine · 2018 · 99 citations · Full text

, , +17

&lt;p&gt;EZH2 Contributes To Cisplatin Resistance In Breast Cancer By Epigenetically Suppressing miR-381 Expression&lt;/p&gt;

Dongwei Dou, Xin Ge, Xinxing Wang et al. · OncoTargets and Therapy · 2019 · 34 citations · Full text

, , +16

NAMPT regulates PKM2 nuclear location through 14‐3‐3ζ: Conferring resistance to tamoxifen in breast cancer

Xin Ge, Yang Zhao, Lingling Dong et al. · Journal of Cellular Physiology · 2019 · 26 citations

, , +17

Diagnosis and surgical treatment of ruptured aneurysm in sinus of Valsalva.

Gaofeng Zhao, Seng Jingjing, Yan Baojun et al. · PubMed · 2003 · 21 citations

, , +14

Inhibition of Mcl-1 enhances Pevonedistat-triggered apoptosis in osteosarcoma cells

Yi Zhang, Chengcheng Shi, Li Yin et al. · Experimental Cell Research · 2017 · 14 citations

, , +14

1–5 of 6